Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Lung Injury Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Pharmacotherapy
1.2.3 Mechanical Ventilation
1.2.4 Adjunctive Procedures
1.2.5 Fluid Management
1.2.6 Others
1.3 Market by Application
1.3.1 Global Acute Lung Injury Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Acute Lung Injury Market Perspective (2018-2033)
2.2 Acute Lung Injury Growth Trends by Region
2.2.1 Global Acute Lung Injury Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Acute Lung Injury Historic Market Size by Region (2018-2023)
2.2.3 Acute Lung Injury Forecasted Market Size by Region (2024-2033)
2.3 Acute Lung Injury Market Dynamics
2.3.1 Acute Lung Injury Industry Trends
2.3.2 Acute Lung Injury Market Drivers
2.3.3 Acute Lung Injury Market Challenges
2.3.4 Acute Lung Injury Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Acute Lung Injury Players by Revenue
3.1.1 Global Top Acute Lung Injury Players by Revenue (2018-2023)
3.1.2 Global Acute Lung Injury Revenue Market Share by Players (2018-2023)
3.2 Global Acute Lung Injury Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Acute Lung Injury Revenue
3.4 Global Acute Lung Injury Market Concentration Ratio
3.4.1 Global Acute Lung Injury Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Lung Injury Revenue in 2022
3.5 Acute Lung Injury Key Players Head office and Area Served
3.6 Key Players Acute Lung Injury Product Solution and Service
3.7 Date of Enter into Acute Lung Injury Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Acute Lung Injury Breakdown Data by Type
4.1 Global Acute Lung Injury Historic Market Size by Type (2018-2023)
4.2 Global Acute Lung Injury Forecasted Market Size by Type (2024-2033)
5 Acute Lung Injury Breakdown Data by Application
5.1 Global Acute Lung Injury Historic Market Size by Application (2018-2023)
5.2 Global Acute Lung Injury Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Acute Lung Injury Market Size (2018-2033)
6.2 North America Acute Lung Injury Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Acute Lung Injury Market Size by Country (2018-2023)
6.4 North America Acute Lung Injury Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Acute Lung Injury Market Size (2018-2033)
7.2 Europe Acute Lung Injury Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Acute Lung Injury Market Size by Country (2018-2023)
7.4 Europe Acute Lung Injury Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Acute Lung Injury Market Size (2018-2033)
8.2 Asia-Pacific Acute Lung Injury Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Acute Lung Injury Market Size by Region (2018-2023)
8.4 Asia-Pacific Acute Lung Injury Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Acute Lung Injury Market Size (2018-2033)
9.2 Latin America Acute Lung Injury Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Acute Lung Injury Market Size by Country (2018-2023)
9.4 Latin America Acute Lung Injury Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Acute Lung Injury Market Size (2018-2033)
10.2 Middle East & Africa Acute Lung Injury Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Acute Lung Injury Market Size by Country (2018-2023)
10.4 Middle East & Africa Acute Lung Injury Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Altor BioScience
11.1.1 Altor BioScience Company Detail
11.1.2 Altor BioScience Business Overview
11.1.3 Altor BioScience Acute Lung Injury Introduction
11.1.4 Altor BioScience Revenue in Acute Lung Injury Business (2018-2023)
11.1.5 Altor BioScience Recent Development
11.2 FirstString Research
11.2.1 FirstString Research Company Detail
11.2.2 FirstString Research Business Overview
11.2.3 FirstString Research Acute Lung Injury Introduction
11.2.4 FirstString Research Revenue in Acute Lung Injury Business (2018-2023)
11.2.5 FirstString Research Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Detail
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Acute Lung Injury Introduction
11.3.4 GlaxoSmithKline Revenue in Acute Lung Injury Business (2018-2023)
11.3.5 GlaxoSmithKline Recent Development
11.4 Forschung und Entwicklung
11.4.1 Forschung und Entwicklung Company Detail
11.4.2 Forschung und Entwicklung Business Overview
11.4.3 Forschung und Entwicklung Acute Lung Injury Introduction
11.4.4 Forschung und Entwicklung Revenue in Acute Lung Injury Business (2018-2023)
11.4.5 Forschung und Entwicklung Recent Development
11.5 Commence Bio
11.5.1 Commence Bio Company Detail
11.5.2 Commence Bio Business Overview
11.5.3 Commence Bio Acute Lung Injury Introduction
11.5.4 Commence Bio Revenue in Acute Lung Injury Business (2018-2023)
11.5.5 Commence Bio Recent Development
11.6 CompleGen
11.6.1 CompleGen Company Detail
11.6.2 CompleGen Business Overview
11.6.3 CompleGen Acute Lung Injury Introduction
11.6.4 CompleGen Revenue in Acute Lung Injury Business (2018-2023)
11.6.5 CompleGen Recent Development
11.7 Histocell S.L.
11.7.1 Histocell S.L. Company Detail
11.7.2 Histocell S.L. Business Overview
11.7.3 Histocell S.L. Acute Lung Injury Introduction
11.7.4 Histocell S.L. Revenue in Acute Lung Injury Business (2018-2023)
11.7.5 Histocell S.L. Recent Development
11.8 Stemedica Cell Technologies
11.8.1 Stemedica Cell Technologies Company Detail
11.8.2 Stemedica Cell Technologies Business Overview
11.8.3 Stemedica Cell Technologies Acute Lung Injury Introduction
11.8.4 Stemedica Cell Technologies Revenue in Acute Lung Injury Business (2018-2023)
11.8.5 Stemedica Cell Technologies Recent Development
11.9 Windtree Therapeutics
11.9.1 Windtree Therapeutics Company Detail
11.9.2 Windtree Therapeutics Business Overview
11.9.3 Windtree Therapeutics Acute Lung Injury Introduction
11.9.4 Windtree Therapeutics Revenue in Acute Lung Injury Business (2018-2023)
11.9.5 Windtree Therapeutics Recent Development
11.10 S-Evans Biosciences
11.10.1 S-Evans Biosciences Company Detail
11.10.2 S-Evans Biosciences Business Overview
11.10.3 S-Evans Biosciences Acute Lung Injury Introduction
11.10.4 S-Evans Biosciences Revenue in Acute Lung Injury Business (2018-2023)
11.10.5 S-Evans Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Acute Lung Injury Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Pharmacotherapy
Table 3. Key Players of Mechanical Ventilation
Table 4. Key Players of Adjunctive Procedures
Table 5. Key Players of Fluid Management
Table 6. Key Players of Others
Table 7. Global Acute Lung Injury Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Acute Lung Injury Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Acute Lung Injury Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Acute Lung Injury Market Share by Region (2018-2023)
Table 11. Global Acute Lung Injury Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Acute Lung Injury Market Share by Region (2024-2033)
Table 13. Acute Lung Injury Market Trends
Table 14. Acute Lung Injury Market Drivers
Table 15. Acute Lung Injury Market Challenges
Table 16. Acute Lung Injury Market Restraints
Table 17. Global Acute Lung Injury Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Acute Lung Injury Market Share by Players (2018-2023)
Table 19. Global Top Acute Lung Injury Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Lung Injury as of 2022)
Table 20. Ranking of Global Top Acute Lung Injury Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Acute Lung Injury Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Acute Lung Injury Product Solution and Service
Table 24. Date of Enter into Acute Lung Injury Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Acute Lung Injury Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Acute Lung Injury Revenue Market Share by Type (2018-2023)
Table 28. Global Acute Lung Injury Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Acute Lung Injury Revenue Market Share by Type (2024-2033)
Table 30. Global Acute Lung Injury Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Acute Lung Injury Revenue Market Share by Application (2018-2023)
Table 32. Global Acute Lung Injury Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Acute Lung Injury Revenue Market Share by Application (2024-2033)
Table 34. North America Acute Lung Injury Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. North America Acute Lung Injury Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Acute Lung Injury Market Size by Country (2024-2033) & (US$ Million)
Table 37. Europe Acute Lung Injury Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. Europe Acute Lung Injury Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Acute Lung Injury Market Size by Country (2024-2033) & (US$ Million)
Table 40. Asia-Pacific Acute Lung Injury Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 41. Asia-Pacific Acute Lung Injury Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Acute Lung Injury Market Size by Region (2024-2033) & (US$ Million)
Table 43. Latin America Acute Lung Injury Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Latin America Acute Lung Injury Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Acute Lung Injury Market Size by Country (2024-2033) & (US$ Million)
Table 46. Middle East & Africa Acute Lung Injury Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Middle East & Africa Acute Lung Injury Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Acute Lung Injury Market Size by Country (2024-2033) & (US$ Million)
Table 49. Altor BioScience Company Detail
Table 50. Altor BioScience Business Overview
Table 51. Altor BioScience Acute Lung Injury Product
Table 52. Altor BioScience Revenue in Acute Lung Injury Business (2018-2023) & (US$ Million)
Table 53. Altor BioScience Recent Development
Table 54. FirstString Research Company Detail
Table 55. FirstString Research Business Overview
Table 56. FirstString Research Acute Lung Injury Product
Table 57. FirstString Research Revenue in Acute Lung Injury Business (2018-2023) & (US$ Million)
Table 58. FirstString Research Recent Development
Table 59. GlaxoSmithKline Company Detail
Table 60. GlaxoSmithKline Business Overview
Table 61. GlaxoSmithKline Acute Lung Injury Product
Table 62. GlaxoSmithKline Revenue in Acute Lung Injury Business (2018-2023) & (US$ Million)
Table 63. GlaxoSmithKline Recent Development
Table 64. Forschung und Entwicklung Company Detail
Table 65. Forschung und Entwicklung Business Overview
Table 66. Forschung und Entwicklung Acute Lung Injury Product
Table 67. Forschung und Entwicklung Revenue in Acute Lung Injury Business (2018-2023) & (US$ Million)
Table 68. Forschung und Entwicklung Recent Development
Table 69. Commence Bio Company Detail
Table 70. Commence Bio Business Overview
Table 71. Commence Bio Acute Lung Injury Product
Table 72. Commence Bio Revenue in Acute Lung Injury Business (2018-2023) & (US$ Million)
Table 73. Commence Bio Recent Development
Table 74. CompleGen Company Detail
Table 75. CompleGen Business Overview
Table 76. CompleGen Acute Lung Injury Product
Table 77. CompleGen Revenue in Acute Lung Injury Business (2018-2023) & (US$ Million)
Table 78. CompleGen Recent Development
Table 79. Histocell S.L. Company Detail
Table 80. Histocell S.L. Business Overview
Table 81. Histocell S.L. Acute Lung Injury Product
Table 82. Histocell S.L. Revenue in Acute Lung Injury Business (2018-2023) & (US$ Million)
Table 83. Histocell S.L. Recent Development
Table 84. Stemedica Cell Technologies Company Detail
Table 85. Stemedica Cell Technologies Business Overview
Table 86. Stemedica Cell Technologies Acute Lung Injury Product
Table 87. Stemedica Cell Technologies Revenue in Acute Lung Injury Business (2018-2023) & (US$ Million)
Table 88. Stemedica Cell Technologies Recent Development
Table 89. Windtree Therapeutics Company Detail
Table 90. Windtree Therapeutics Business Overview
Table 91. Windtree Therapeutics Acute Lung Injury Product
Table 92. Windtree Therapeutics Revenue in Acute Lung Injury Business (2018-2023) & (US$ Million)
Table 93. Windtree Therapeutics Recent Development
Table 94. S-Evans Biosciences Company Detail
Table 95. S-Evans Biosciences Business Overview
Table 96. S-Evans Biosciences Acute Lung Injury Product
Table 97. S-Evans Biosciences Revenue in Acute Lung Injury Business (2018-2023) & (US$ Million)
Table 98. S-Evans Biosciences Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Lung Injury Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Acute Lung Injury Market Share by Type: 2022 VS 2033
Figure 3. Pharmacotherapy Features
Figure 4. Mechanical Ventilation Features
Figure 5. Adjunctive Procedures Features
Figure 6. Fluid Management Features
Figure 7. Others Features
Figure 8. Global Acute Lung Injury Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 9. Global Acute Lung Injury Market Share by Application: 2022 VS 2033
Figure 10. Hospitals Case Studies
Figure 11. Clinics Case Studies
Figure 12. Others Case Studies
Figure 13. Acute Lung Injury Report Years Considered
Figure 14. Global Acute Lung Injury Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Acute Lung Injury Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Acute Lung Injury Market Share by Region: 2022 VS 2033
Figure 17. Global Acute Lung Injury Market Share by Players in 2022
Figure 18. Global Top Acute Lung Injury Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Lung Injury as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Acute Lung Injury Revenue in 2022
Figure 20. North America Acute Lung Injury Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Acute Lung Injury Market Share by Country (2018-2033)
Figure 22. United States Acute Lung Injury Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Acute Lung Injury Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Acute Lung Injury Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Acute Lung Injury Market Share by Country (2018-2033)
Figure 26. Germany Acute Lung Injury Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Acute Lung Injury Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Acute Lung Injury Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Acute Lung Injury Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Acute Lung Injury Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Acute Lung Injury Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Acute Lung Injury Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Acute Lung Injury Market Share by Region (2018-2033)
Figure 34. China Acute Lung Injury Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan Acute Lung Injury Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea Acute Lung Injury Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia Acute Lung Injury Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India Acute Lung Injury Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia Acute Lung Injury Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Acute Lung Injury Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Acute Lung Injury Market Share by Country (2018-2033)
Figure 42. Mexico Acute Lung Injury Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil Acute Lung Injury Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Acute Lung Injury Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Acute Lung Injury Market Share by Country (2018-2033)
Figure 46. Turkey Acute Lung Injury Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia Acute Lung Injury Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Altor BioScience Revenue Growth Rate in Acute Lung Injury Business (2018-2023)
Figure 49. FirstString Research Revenue Growth Rate in Acute Lung Injury Business (2018-2023)
Figure 50. GlaxoSmithKline Revenue Growth Rate in Acute Lung Injury Business (2018-2023)
Figure 51. Forschung und Entwicklung Revenue Growth Rate in Acute Lung Injury Business (2018-2023)
Figure 52. Commence Bio Revenue Growth Rate in Acute Lung Injury Business (2018-2023)
Figure 53. CompleGen Revenue Growth Rate in Acute Lung Injury Business (2018-2023)
Figure 54. Histocell S.L. Revenue Growth Rate in Acute Lung Injury Business (2018-2023)
Figure 55. Stemedica Cell Technologies Revenue Growth Rate in Acute Lung Injury Business (2018-2023)
Figure 56. Windtree Therapeutics Revenue Growth Rate in Acute Lung Injury Business (2018-2023)
Figure 57. S-Evans Biosciences Revenue Growth Rate in Acute Lung Injury Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed